News | May 02, 2026
FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada
Two-day long National Health Summit highlighted progress under the NHM and called for data-driven and SDG-aligned health system reforms
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies
Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice
_256_384.png)
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
Subscribe To Our Newsletter & Stay Updated
